Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-04

FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (AvKARE)

View source ↗

Summary

The FDA approved AvKARE's generic fixed-dose combination of telmisartan and hydrochlorothiazide for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

ORIG AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)